<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01840657</url>
  </required_header>
  <id_info>
    <org_study_id>CMDIR-002</org_study_id>
    <nct_id>NCT01840657</nct_id>
  </id_info>
  <brief_title>Myotubular Myopathy Event Study</brief_title>
  <acronym>MTMES</acronym>
  <official_title>Prospective Study of Adverse Event Rates in Males With X-Linked Myotubular Myopathy</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Cure CMD</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Congenital Muscle Disease International Registr</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>University of Michigan</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Cure CMD</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      X-Linked myotubular myopathy (XLMTM), a form of centronuclear myopathy (CNM) is the result of
      a mutation in the MTM1 (myotubularin) gene which leads to altered myotubularin. Myotubularin
      is essential for optimum muscle function. To date, over 100 mutations have been described
      resulting in a range of disease onset and symptom severity. The early onset form presents
      with neonatal hypotonia, muscle weakness, respiratory distress and an ongoing requirement for
      continuous ventilatory support with the inability to maintain a sitting position once placed.
      Males with both later onset and milder symptoms usually do not require ongoing ventilatory
      support, achieve a higher maximal motor function with ability to sit when placed and even
      walk, and have improved survival rates. Males with XLMTM may experience complications
      (events) at birth and throughout their lifetime. The goal of the study is to identify the
      number of events over twelve months in males with genetically confirmed XLMTM. Parents or
      affected individuals over the age of 18 years who are able to access telephone will provide
      answers to an established event survey to evaluate the frequency and types of events.
      Emergency department, hospital admissions and mortality will be confirmed by obtaining
      medical reports.

      The investigators hypothesize that there will be no association between the frequency of
      events and markers of clinical severity including the need for ventilatory support at birth,
      current level of ventilatory support (no support, support less than 12 hours, support more
      than 12 hours) and current motor function (walking, sitting without support, inability to sit
      without support).
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">April 2013</start_date>
  <completion_date type="Actual">October 2015</completion_date>
  <primary_completion_date type="Actual">October 2015</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Only</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Survey of a defined set of events</measure>
    <time_frame>12 months</time_frame>
    <description>Changes in care needed, breathing support, motor ability, medications and medical care, nutrition/weight management, communication/vision/learning/behavior, and frequency of outpatient/hospital/ER visits are recorded by a monthly telephone survey.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Frequency of a predefined set of events related to ventilatory status</measure>
    <time_frame>12 months</time_frame>
    <description>To analyze the strength of the association between the frequency of events surveyed and 1) duration of ventilatory support directly after birth and 2) current need for ventilatory support.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Frequency of a predefined set of events related to current motor function</measure>
    <time_frame>12 months</time_frame>
    <description>To analyze the strength of the association between the frequency of events surveyed and current motor function</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Association between event frequency and genotype</measure>
    <time_frame>12 months</time_frame>
    <description>To determine the strength of the association between the frequency of the events surveyed and the affected individual's genotype.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Association between event rate and season</measure>
    <time_frame>12 months</time_frame>
    <description>To analyze event rates with respect to two seasonal clusters, October through March and April through September.</description>
  </secondary_outcome>
  <enrollment type="Actual">33</enrollment>
  <condition>X-linked Myotubular Myopathy</condition>
  <eligibility>
    <study_pop>
      <textblock>
        Participants for the MTM Event study will be recruited from 2 sources:

          -  the Centronculear Myopathy Natural History Study and

          -  the Congenital Muscle Disease International Registry (CMDIR)
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  males with a confirmed MTM1 mutation OR

          -  males with a muscle biopsy consistent with myotubular myopathy AND family history
             consistent with X-linked inheritance AND

          -  English-speaking parent/guardian of a living male child or a decisionally impaired
             adult OR English-speaking affected male over 18 years of age who can access telephone

          -  signed study consent

          -  enrolled in the Congenital Muscle Disease International Registry (CMDIR)

        Exclusion Criteria:

          -  males with only a clinical diagnosis of XLMTM but without family history of XLMTM

          -  an affected male who has a genetically confirmed form of centronuclear myopathy (CNM)
             that is not caused by a mutation in the MTM1 gene

          -  females with MTM1 due to the limited number of females affected and the variability of
             clinical presentation
      </textblock>
    </criteria>
    <gender>Male</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Joseph Hornyak, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Michigan</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Anne Rutkowski, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Cure CMD</affiliation>
  </overall_official>
  <overall_official>
    <last_name>James Dowling, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Michigan</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>CMDIR</name>
      <address>
        <city>Torrance</city>
        <state>California</state>
        <zip>90502</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <reference>
    <citation>Al-Qusairi L, Laporte J. T-tubule biogenesis and triad formation in skeletal muscle and implication in human diseases. Skelet Muscle. 2011 Jul 13;1(1):26. doi: 10.1186/2044-5040-1-26.</citation>
    <PMID>21797990</PMID>
  </reference>
  <reference>
    <citation>Al-Qusairi L, Weiss N, Toussaint A, Berbey C, Messaddeq N, Kretz C, Sanoudou D, Beggs AH, Allard B, Mandel JL, Laporte J, Jacquemond V, Buj-Bello A. T-tubule disorganization and defective excitation-contraction coupling in muscle fibers lacking myotubularin lipid phosphatase. Proc Natl Acad Sci U S A. 2009 Nov 3;106(44):18763-8. doi: 10.1073/pnas.0900705106. Epub 2009 Oct 21.</citation>
    <PMID>19846786</PMID>
  </reference>
  <reference>
    <citation>Beggs AH, Böhm J, Snead E, Kozlowski M, Maurer M, Minor K, Childers MK, Taylor SM, Hitte C, Mickelson JR, Guo LT, Mizisin AP, Buj-Bello A, Tiret L, Laporte J, Shelton GD. MTM1 mutation associated with X-linked myotubular myopathy in Labrador Retrievers. Proc Natl Acad Sci U S A. 2010 Aug 17;107(33):14697-702. doi: 10.1073/pnas.1003677107. Epub 2010 Aug 3.</citation>
    <PMID>20682747</PMID>
  </reference>
  <reference>
    <citation>Biancalana V, Caron O, Gallati S, Baas F, Kress W, Novelli G, D'Apice MR, Lagier-Tourenne C, Buj-Bello A, Romero NB, Mandel JL. Characterisation of mutations in 77 patients with X-linked myotubular myopathy, including a family with a very mild phenotype. Hum Genet. 2003 Feb;112(2):135-42. Epub 2002 Nov 28.</citation>
    <PMID>12522554</PMID>
  </reference>
  <reference>
    <citation>Buj-Bello A, Biancalana V, Moutou C, Laporte J, Mandel JL. Identification of novel mutations in the MTM1 gene causing severe and mild forms of X-linked myotubular myopathy. Hum Mutat. 1999;14(4):320-5.</citation>
    <PMID>10502779</PMID>
  </reference>
  <reference>
    <citation>Buj-Bello A, Fougerousse F, Schwab Y, Messaddeq N, Spehner D, Pierson CR, Durand M, Kretz C, Danos O, Douar AM, Beggs AH, Schultz P, Montus M, Denèfle P, Mandel JL. AAV-mediated intramuscular delivery of myotubularin corrects the myotubular myopathy phenotype in targeted murine muscle and suggests a function in plasma membrane homeostasis. Hum Mol Genet. 2008 Jul 15;17(14):2132-43. doi: 10.1093/hmg/ddn112. Epub 2008 Apr 22.</citation>
    <PMID>18434328</PMID>
  </reference>
  <reference>
    <citation>Cao C, Backer JM, Laporte J, Bedrick EJ, Wandinger-Ness A. Sequential actions of myotubularin lipid phosphatases regulate endosomal PI(3)P and growth factor receptor trafficking. Mol Biol Cell. 2008 Aug;19(8):3334-46. doi: 10.1091/mbc.E08-04-0367. Epub 2008 Jun 4.</citation>
    <PMID>18524850</PMID>
  </reference>
  <reference>
    <citation>Das S, Dowling J, Pierson CR. X-Linked Centronuclear Myopathy. 2002 Feb 25 [updated 2011 Oct 6]. In: Adam MP, Ardinger HH, Pagon RA, Wallace SE, Bean LJH, Stephens K, Amemiya A, editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2018. Available from http://www.ncbi.nlm.nih.gov/books/NBK1432/</citation>
    <PMID>20301605</PMID>
  </reference>
  <reference>
    <citation>de Gouyon BM, Zhao W, Laporte J, Mandel JL, Metzenberg A, Herman GE. Characterization of mutations in the myotubularin gene in twenty six patients with X-linked myotubular myopathy. Hum Mol Genet. 1997 Sep;6(9):1499-504.</citation>
    <PMID>9285787</PMID>
  </reference>
  <reference>
    <citation>Dowling JJ, Gibbs EM, Feldman EL. Membrane traffic and muscle: lessons from human disease. Traffic. 2008 Jul;9(7):1035-43. doi: 10.1111/j.1600-0854.2008.00716.x. Epub 2008 Feb 4. Review.</citation>
    <PMID>18266915</PMID>
  </reference>
  <reference>
    <citation>Dowling JJ, Vreede AP, Low SE, Gibbs EM, Kuwada JY, Bonnemann CG, Feldman EL. Loss of myotubularin function results in T-tubule disorganization in zebrafish and human myotubular myopathy. PLoS Genet. 2009 Feb;5(2):e1000372. doi: 10.1371/journal.pgen.1000372. Epub 2009 Feb 6.</citation>
    <PMID>19197364</PMID>
  </reference>
  <reference>
    <citation>Herman GE, Finegold M, Zhao W, de Gouyon B, Metzenberg A. Medical complications in long-term survivors with X-linked myotubular myopathy. J Pediatr. 1999 Feb;134(2):206-14.</citation>
    <PMID>9931531</PMID>
  </reference>
  <reference>
    <citation>Herman GE, Kopacz K, Zhao W, Mills PL, Metzenberg A, Das S. Characterization of mutations in fifty North American patients with X-linked myotubular myopathy. Hum Mutat. 2002 Feb;19(2):114-21.</citation>
    <PMID>11793470</PMID>
  </reference>
  <reference>
    <citation>Hoffjan S, Thiels C, Vorgerd M, Neuen-Jacob E, Epplen JT, Kress W. Extreme phenotypic variability in a German family with X-linked myotubular myopathy associated with E404K mutation in MTM1. Neuromuscul Disord. 2006 Nov;16(11):749-53. Epub 2006 Sep 26.</citation>
    <PMID>17005396</PMID>
  </reference>
  <reference>
    <citation>Joseph M, Pai GS, Holden KR, Herman G. X-linked myotubular myopathy: clinical observations in ten additional cases. Am J Med Genet. 1995 Nov 6;59(2):168-73.</citation>
    <PMID>8588581</PMID>
  </reference>
  <reference>
    <citation>Jungbluth H, Wallgren-Pettersson C, Laporte J. Centronuclear (myotubular) myopathy. Orphanet J Rare Dis. 2008 Sep 25;3:26. doi: 10.1186/1750-1172-3-26. Review.</citation>
    <PMID>18817572</PMID>
  </reference>
  <reference>
    <citation>Laporte J, Biancalana V, Tanner SM, Kress W, Schneider V, Wallgren-Pettersson C, Herger F, Buj-Bello A, Blondeau F, Liechti-Gallati S, Mandel JL. MTM1 mutations in X-linked myotubular myopathy. Hum Mutat. 2000;15(5):393-409. Review.</citation>
    <PMID>10790201</PMID>
  </reference>
  <reference>
    <citation>Lee IC, Su PH, Chen JY, Hu JM, Lu JJ, Ng YY. Congenital myotubular myopathy with a novel MTM1 gene mutation in a premature infant presenting with ventilator dependency and intrahepatic cholestasis. J Child Neurol. 2012 Jan;27(1):99-104. doi: 10.1177/0883073811414419. Epub 2011 Aug 31.</citation>
    <PMID>21881007</PMID>
  </reference>
  <reference>
    <citation>Pénisson-Besnier I, Biancalana V, Reynier P, Cossée M, Dubas F. Diagnosis of myotubular myopathy in the oldest known manifesting female carrier: a clinical and genetic study. Neuromuscul Disord. 2007 Feb;17(2):180-5. Epub 2007 Jan 23.</citation>
    <PMID>17251023</PMID>
  </reference>
  <reference>
    <citation>Romero NB, Bitoun M. Centronuclear myopathies. Semin Pediatr Neurol. 2011 Dec;18(4):250-6. doi: 10.1016/j.spen.2011.10.006. Review.</citation>
    <PMID>22172420</PMID>
  </reference>
  <reference>
    <citation>Robinson FL, Dixon JE. Myotubularin phosphatases: policing 3-phosphoinositides. Trends Cell Biol. 2006 Aug;16(8):403-12. Epub 2006 Jul 7. Review.</citation>
    <PMID>16828287</PMID>
  </reference>
  <verification_date>January 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>April 18, 2013</study_first_submitted>
  <study_first_submitted_qc>April 23, 2013</study_first_submitted_qc>
  <study_first_posted type="Estimate">April 26, 2013</study_first_posted>
  <last_update_submitted>March 5, 2018</last_update_submitted>
  <last_update_submitted_qc>March 5, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">March 7, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>CMDIR (Congenital Muscle Disease International Registry)</keyword>
  <keyword>X-linked myotubular myopathy</keyword>
  <keyword>centronuclear myopathy</keyword>
  <keyword>myotubularin</keyword>
  <keyword>MTM1 gene</keyword>
  <keyword>mutation</keyword>
  <keyword>survival</keyword>
  <keyword>adverse event</keyword>
  <keyword>disease complication</keyword>
  <keyword>hospital admission</keyword>
  <keyword>emergency room visit</keyword>
  <keyword>motor function</keyword>
  <keyword>respiratory function</keyword>
  <keyword>natural history study</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Muscular Diseases</mesh_term>
    <mesh_term>Myopathies, Structural, Congenital</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

